Management Team

Jamie Macdonald

Chief Executive Officer

Jamie Macdonald is Chief Executive Officer of Parexel®. A seasoned leader of the clinical research industry, Mr. Macdonald holds nearly 25 years of leadership experience with leading global biopharmaceutical services companies.

Prior to joining Parexel®, Mr. Macdonald led INC Research, now known as Syneos Health, for several years first as CEO and later as Vice Chairman. As CEO, he was responsible for all aspects of INC’s business, performance and strategy. During his time at INC Research, Mr. Macdonald led the Company to industry-leading growth and margins, delivered strong operational and market performance, and undertook a successful Initial Public Offering in 2014.

Mr. Macdonald also served as INC’s Chief Operating Officer, and previously held several leadership positions in the biopharmaceutical services industry, including Senior Vice President and Head of Global Project Management at Quintiles, now known as IQVIA. Prior to this time, he held various senior operational and finance roles at Quintiles. He also served as Chairman of the Association of Clinical Research Organizations (ACRO) Board of Directors in 2015.

Mr. Macdonald began his career in the pharmaceutical industry with Syntex Corporation (acquired by Roche Holdings, Inc.). A native of Scotland, he holds a B.A. in Economics from Heriot-Watt University in Edinburgh, Scotland and is a qualified Chartered Management Accountant (ACMA).

Peyton Howell

Executive Vice President, Chief Commercial & Strategy Officer

Peyton Howell is Executive Vice President and Chief Commercial and Strategy Officer at Parexel®.  She has over 25 years of leadership experience in the healthcare industry, successfully delivering solutions that meet the needs of customers.

Prior to joining Parexel®, Ms. Howell held several leadership positions with AmerisourceBergen, most recently as Executive Vice President and President, Health Systems and Specialty Care Solutions.  In that role, Ms. Howell led a business unit with market-leading share of specialty and biotech products and solutions for physicians, health systems and specialty pharmacy customers.

Previously, Ms. Howell was Executive Vice President and President, Global Sourcing and Manufacturer Relations with AmerisourceBergen, and led pharmaceutical manufacturer strategy and relationships for the company, including multi-billion-dollar sourcing activities.  As part of this role, she led the creation of a new sourcing entity in Bern, Switzerland to support global manufacturer relations.

Ms. Howell also previously served as President, Consulting Services for AmerisourceBergen, managing a portfolio of industry-leading companies focused on partnering with pharmaceutical manufacturers to achieve success with market access, reimbursement, specialty services and product commercialization.  In addition, she was a founder of Lash Group and served as its President for 10 years after the company was acquired by AmerisourceBergen in 1998.

Ms. Howell is a nationally-recognized speaker and author on health policy and market access issues, and started her career in hospitals, including Ohio State Medical Center, where she worked to address reimbursement challenges for new, emerging technologies.  Ms. Howell is also a member of the Healthcare Financial Management Association (HFMA), American College of Healthcare Executives (ACHE) and the Academy of Managed Care Pharmacy (AMCP).  Her honors include being recognized as the 2004 Charlotte, North Carolina Businesswoman of the Year and in 2013 she received a Distinguished Alumni Award from The Ohio State University.

Ms. Howell holds a Master in Health Administration (MHA) from The Ohio State University and a BA from the University of Illinois.

Greg Rush

Executive Vice President, Chief Financial Officer

Greg Rush is Executive Vice President and Chief Financial Officer at Parexel® and brings to the Company years of experience leading global financial operations within the CRO and service industries.

Prior to joining Parexel®, Mr. Rush served as Executive Vice President and Chief Financial Officer of Syneos Health, Inc. (formerly known as INC Research Holdings, Inc.) from August 2013 to February 2018. In that role, Mr. Rush oversaw the Company’s global financial operations, including Finance, Accounting, Tax, Treasury, Budgeting, M&A and Financial Planning, as well as all Information Technology functions.

Previously, Mr. Rush was Senior Vice President and CFO of Tekelec, a leading high-tech solutions and service provider that was acquired by Oracle. Mr. Rush also held positions of increasing responsibility at Siebel Systems, Quintiles Transnational Holdings, PricewaterhouseCoopers and Ernst & Young. In his roles, Mr. Rush has had repeated success in developing innovative financial management strategies, strong capital structures, high levels of operational support and sound corporate governance. He has experience in both private and public capital markets, completing more than 50 debt and equity financing transactions, including private equity transactions, initial public offerings (IPOs) and secondary offerings.

Mr. Rush is a Certified Public Accountant and holds a Bachelor of Science in Business Administration and a Master of Accounting from the University of North Carolina at Chapel Hill.

Michael Crowley

Executive Vice President, General Counsel and Secretary

Mr. Crowley is Executive Vice President and General Counsel and Secretary of Parexel®.  In this capacity, he is responsible for the Company's worldwide legal, risk management, ethics & compliance and corporate governance.  Mr. Crowley is a member of the Business Review Committee (BRC), the Company’s most senior leadership team.

Mr. Crowley brings to Parexel® extensive commercial and corporate legal experience. He has provided counsel on a wide range of matters including commercial contracting, strategic alliances, corporate governance, mergers and acquisitions, compliance and ethics and intellectual property. Since joining Parexel® in 2009, Mr. Crowley has held several key positions in the Legal & Risk Management organization, including most recently overseeing legal support for the Company’s commercial contracting and clinical operations organizations.  Prior to joining Parexel®, Mr. Crowley was Vice President and General Counsel at Netezza Corporation, a publicly-traded technology company. Mr. Crowley was previously with CA, Inc. and Concord Communications, Inc.

Mr. Crowley received his J.D. degree from Northeastern University School of Law. He also holds a Bachelor of Arts degree in History from the University of Miami and a Master of Arts degree in European History from the University of Rhode Island.

Michele Fournier

Executive Vice President, Chief Human Resources Officer

Michele Fournier, Executive Vice President and Chief Human Resources Officer, works in partnership with our executive leaders to drive high performance and develop the people and growth strategies. As Chief Human Resources Officer, she is responsible for the global management of Parexel’s HR operations, as well as the compensation and benefits, learning and development, leadership and organizational development, people analytics, and talent acquisition centers of excellence, as well as the Company’s diversity and inclusion initiatives.

In her role as Executive Vice President, Ms. Fournier has global responsibility for the design and management of all Parexel® total reward programs, and has led the compensation, benefits, payroll, HRIS and HR M&A functions during her tenure.

Prior to joining Parexel®, Ms. Fournier held a variety of senior Human Resource leadership roles in the United States and abroad, having completed several short-term expat assignments in various European offices. Most recently, she was Corporate Vice President of Global Human Resources and Corporate Services at PTC in Needham, Massachusetts. She also worked as a consultant and held compensation and benefit leadership positions at Cambridge Technology Partners (CTP), William M. Mercer, and Medtronic.

Ms. Fournier has a keen interest in innovational approaches to elementary and secondary education and personalized learning. She currently serves as the Chair of the Board of Directors at the Tremont School in Lexington, Massachusetts.

Ms. Fournier earned a Bachelor of Arts from the University of Michigan and is a Certified Compensation Professional (CCP).

Sy Pretorius, M.D.

Executive Vice President, Chief Medical & Scientific Officer

Sy Pretorius is Executive Vice President and Chief Medical & Scientific Officer at Parexel® and has been with Parexel for the past twenty years in a variety of roles and countries. On a day-to-day basis, Dr. Pretorius collaborates closely with biopharmaceutical and medical device clients in designing and optimizing drug / device development strategies and plans, as well as finding, evaluating and purchasing assets.

Dr. Pretorius is responsible for the overall leadership of a number of Parexel® business units – these include our global Early Phase business (responsible for Phase I and II clinical development), Global Medical Services (therapeutic area expertize, global medical writing and pharmacovigilance operations), Quantitative Clinical Development (modeling and simulation), as well as the Genomic Medicine unit.

Dr. Pretorius is absolutely passionate about drug development and leads several company-wide forums and initiatives focused on clinical trial innovation and further expanding Parexel’s capabilities and service offering.

Dr. Pretorius is a Medical Doctor (M.B.,Ch.B) with Masters degrees in Clinical Pharmacology (M.Med.Sc), Business Administration (MBA) and, most recently in the Management of Drug Development (MS) from the University of Southern California (USC). Dr. Pretorius has and continues to publish and present extensively. 

Gadi Saarony

Executive Vice President, Chief Clinical Research Services Officer

Gadi Saarony, Executive Vice President and Chief Clinical Research Services Officer, is responsible for the operational delivery of Parexel’s clinical research services. His global remit includes site strategy and selection, patient recruitment, data management, biostatistics and programming, clinical operations, project management and resourcing. In his role, Mr. Saarony also works closely with Parexel’s Strategic Partnerships and key accounts. He is a member of the Business Review Committee (BRC), the Company’s most senior leadership team. 

Prior to assuming his current role, Mr. Saarony held several senior-level positions at Parexel®. He was instrumental in achieving rapid growth in sales and revenue and driving consistently strong profitability performance in our consulting business. Initially, Mr. Saarony joined Parexel in the area of strategy development.   

Before joining Parexel® in 2003, Mr. Saarony served as Director of Consulting Services for Habama, Inc. and Associate Director, Strategy, with Ernst & Young, LLP, Inc. He graduated from Rider University with a Bachelor of Science in Economics and holds a Master’s degree in International Business from The American Graduate School of International Business (now Thunderbird School of Global Management). 

We are always available for a conversation.